Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up Study
- PMID: 34515212
- PMCID: PMC8450855
- DOI: 10.1159/000518141
Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up Study
Abstract
Background: Long-term pulmonary sequelae following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia are not yet confirmed; however, preliminary observations suggest a possible relevant clinical, functional, and radiological impairment.
Objectives: The aim of this study was to identify and characterize pulmonary sequelae caused by SARS-CoV-2 pneumonia at 6-month follow-up.
Methods: In this multicentre, prospective, observational cohort study, patients hospitalized for SARS-CoV-2 pneumonia and without prior diagnosis of structural lung diseases were stratified by maximum ventilatory support ("oxygen only," "continuous positive airway pressure," and "invasive mechanical ventilation") and followed up at 6 months from discharge. Pulmonary function tests and diffusion capacity for carbon monoxide (DLCO), 6-min walking test, chest X-ray, physical examination, and modified Medical Research Council (mMRC) dyspnoea score were collected.
Results: Between March and June 2020, 312 patients were enrolled (83, 27% women; median interquartile range age 61.1 [53.4, 69.3] years). The parameters that showed the highest rate of impairment were DLCO and chest X-ray, in 46% and 25% of patients, respectively. However, only a minority of patients reported dyspnoea (31%), defined as mMRC ≥1, or showed restrictive ventilatory defects (9%). In the logistic regression model, having asthma as a comorbidity was associated with DLCO impairment at follow-up, while prophylactic heparin administration during hospitalization appeared as a protective factor. The need for invasive ventilatory support during hospitalization was associated with chest imaging abnormalities.
Conclusions: DLCO and radiological assessment appear to be the most sensitive tools to monitor patients with the coronavirus disease 2019 (COVID-19) during follow-up. Future studies with longer follow-up are warranted to better understand pulmonary sequelae.
Keywords: COVID-19; Follow-up; Pneumonia; Pulmonary fibrosis; Radiology and other imaging; Respiratory function tests.
© 2021 S. Karger AG, Basel.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures


Similar articles
-
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study.Respir Res. 2022 Mar 21;23(1):65. doi: 10.1186/s12931-022-01994-y. Respir Res. 2022. PMID: 35313890 Free PMC article.
-
3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study.Lancet Respir Med. 2021 Jul;9(7):747-754. doi: 10.1016/S2213-2600(21)00174-0. Epub 2021 May 5. Lancet Respir Med. 2021. PMID: 33964245 Free PMC article.
-
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge.JAMA Netw Open. 2021 Jan 4;4(1):e2036142. doi: 10.1001/jamanetworkopen.2020.36142. JAMA Netw Open. 2021. PMID: 33502487 Free PMC article.
-
[Follow-up of patients after COVID-19 pneumonia. Pulmonary sequelae].Rev Alerg Mex. 2020 Oct-Dec;67(4):350-369. doi: 10.29262/ram.v67i4.847. Rev Alerg Mex. 2020. PMID: 33631903 Review. Spanish.
-
Pulmonary function and chest computed tomography abnormalities 6-12 months after recovery from COVID-19: a systematic review and meta-analysis.Respir Res. 2022 Sep 6;23(1):233. doi: 10.1186/s12931-022-02163-x. Respir Res. 2022. PMID: 36068582 Free PMC article.
Cited by
-
Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge.ERJ Open Res. 2022 Apr 11;8(2):00004-2022. doi: 10.1183/23120541.00004-2022. eCollection 2022 Apr. ERJ Open Res. 2022. PMID: 35415186 Free PMC article.
-
Quantitative CT Metrics Associated with Variability in the Diffusion Capacity of the Lung of Post-COVID-19 Patients with Minimal Residual Lung Lesions.J Imaging. 2023 Jul 26;9(8):150. doi: 10.3390/jimaging9080150. J Imaging. 2023. PMID: 37623682 Free PMC article.
-
Post-COVID-19 Symptoms in Adults with Asthma-Systematic Review.Biomedicines. 2023 Aug 14;11(8):2268. doi: 10.3390/biomedicines11082268. Biomedicines. 2023. PMID: 37626764 Free PMC article. Review.
-
Impact of impaired pulmonary function on clinical outcomes in survivors of severe COVID-19 without pre-existing respiratory disease.J Bras Pneumol. 2023 May 26;49(3):e20220452. doi: 10.36416/1806-3756/e20220452. eCollection 2023. J Bras Pneumol. 2023. PMID: 37255163 Free PMC article.
-
Corrigendum to "The prevalence and long-term health effects of long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis".EClinicalMedicine. 2023 May;59:101959. doi: 10.1016/j.eclinm.2023.101959. Epub 2023 Apr 19. EClinicalMedicine. 2023. PMID: 37096187 Free PMC article.
References
-
- Zhang R, Pan Y, Fanelli V, Wu S, Luo AA, Islam D, et al. Mechanical stress and the induction of lung fibrosis via the midkine signaling pathway. Am J Respir Crit Care Med. 2015;192((3)):315–23. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous